(Q38590038)

English

Toward antiviral therapy/prophylaxis for rhinovirus-induced exacerbations of chronic obstructive pulmonary disease: challenges, opportunities, and strategies

scientific article published on 21 September 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Toward antiviral therapy/prophylaxis for rhinovirus-induced exacerbations of chronic obstructive pulmonary disease: challenges, opportunities, and strategies (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

Hendrik Jan Thibaut

object named as

Hendrik Jan Thibaut

1

0 references

object named as

Johan Neyts

6

0 references

author name string

Céline Lacroix

2

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Armando M De Palma

3

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

David Franco

4

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Mark Decramer

5

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

21 September 2015

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Reviews in Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

21-33

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Projections of global mortality and burden of disease from 2002 to 2030

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Infection in the pathogenesis and course of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Predictors for antibiotic prescribing in patients with exacerbations of COPD in general practice

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Infectious etiology of acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study.

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Viral etiology of acute exacerbations of COPD in Hong Kong.

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Viral epidemiology of acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Respiratory viral infection in exacerbations of COPD.

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD.

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Upper-respiratory viral infection, biomarkers, and COPD exacerbations

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Human rhinovirus infection during naturally occurring COPD exacerbations

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Evaluation of a quantitative real-time PCR for the detection of respiratory syncytial virus in pulmonary diseases

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Newly identified human rhinoviruses: molecular methods heat up the cold viruses

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

The airway epithelium: soldier in the fight against respiratory viruses

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Rhinovirus disrupts the barrier function of polarized airway epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Epidemiological relationships between the common cold and exacerbation frequency in COPD.

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Challenges in developing a cross-serotype rhinovirus vaccine.

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Selective inhibitors of picornavirus replication

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

The structure of antiviral agents that inhibit uncoating when complexed with viral capsids

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human Rhinovirus

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

New hepatitis C virus (HCV) drugs and the hope for a cure: concepts in anti-HCV drug development

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

The global status of resistance to antiretroviral drugs

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Rhinovirus genome evolution during experimental human infection

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Modeling of the human rhinovirus C capsid suggests possible causes for antiviral drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

The RNA template channel of the RNA-dependent RNA polymerase as a target for development of antiviral therapy of multiple genera within a virus family

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Time lines of infection and disease in human influenza: a review of volunteer challenge studies

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Performance of six influenza rapid tests in detecting human influenza in clinical specimens.

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Seasonal respiratory syncytial virus prophylaxis based on predetermined dates versus regional surveillance data

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Rhinovirus infections in western Sweden: a four-year molecular epidemiology study comparing local and globally appearing types

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Rhinovirus vaccination: the case against

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

Rhinoviruses promote internalisation of Staphylococcus aureus into non-fully permissive cultured pneumocytes

1 reference

https://api.crossref.org/works/10.1002%2FRMV.1856

21 January 2018

In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26388447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FDA panel rejects common cold treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/26388447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26388447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26388447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of rhinovirus RNA in lower airway cells during experimentally induced infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/26388447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New strains of bacteria and exacerbations of chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26388447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/26388447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/RMV.1856

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38590038&oldid=1769165260"